These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36802270)

  • 21. CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-γ.
    Wang H; Yan Z; Hao J; Yang B; Wang J; Yi L; Wang X; Li S; Zhang H; Zhang S
    Thorac Cancer; 2019 Dec; 10(12):2225-2235. PubMed ID: 31625289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors.
    Knopf P; Stowbur D; Hoffmann SHL; Hermann N; Maurer A; Bucher V; Poxleitner M; Tako B; Sonanini D; Krishnamachary B; Sinharay S; Fehrenbacher B; Gonzalez-Menendez I; Reckmann F; Bomze D; Flatz L; Kramer D; Schaller M; Forchhammer S; Bhujwalla ZM; Quintanilla-Martinez L; Schulze-Osthoff K; Pagel MD; Fransen MF; Röcken M; Martins AF; Pichler BJ; Ghoreschi K; Kneilling M
    Mol Cancer; 2023 Dec; 22(1):207. PubMed ID: 38102680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Concentration of Dezocine Induces Immune Escape of Lung Cancer and Promotes Glucose Metabolism through Up-Regulating PD-L1 and Activating the NF-κB Pathway.
    Dong W; Zhang D; Zhu A; Hu Y; Li W
    Curr Mol Med; 2022; 22(10):919-928. PubMed ID: 34951362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.
    Gowrishankar K; Gunatilake D; Gallagher SJ; Tiffen J; Rizos H; Hersey P
    PLoS One; 2015; 10(4):e0123410. PubMed ID: 25844720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
    Chen J; Jiang CC; Jin L; Zhang XD
    Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response.
    Liu L; Hou J; Xu Y; Qin L; Liu W; Zhang H; Li Y; Chen M; Deng M; Zhao B; Hu J; Zheng H; Li C; Meng S
    PLoS One; 2020; 15(7):e0228302. PubMed ID: 32628668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
    Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
    J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
    Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells.
    Li N; Wang J; Zhang N; Zhuang M; Zong Z; Zou J; Li G; Wang X; Zhou H; Zhang L; Shi Y
    Cancer Immunol Immunother; 2018 Feb; 67(2):271-283. PubMed ID: 29090321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Checkpoint molecule expression by B and T cell lymphomas in dogs.
    Hartley G; Elmslie R; Dow S; Guth A
    Vet Comp Oncol; 2018 Sep; 16(3):352-360. PubMed ID: 29380929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions.
    Ganster RW; Guo Z; Shao L; Geller DA
    J Interferon Cytokine Res; 2005 Nov; 25(11):707-19. PubMed ID: 16318585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.
    Garcia-Diaz A; Shin DS; Moreno BH; Saco J; Escuin-Ordinas H; Rodriguez GA; Zaretsky JM; Sun L; Hugo W; Wang X; Parisi G; Saus CP; Torrejon DY; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Damoiseaux R; Lo RS; Ribas A
    Cell Rep; 2017 May; 19(6):1189-1201. PubMed ID: 28494868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer.
    Falcinelli M; Al-Hity G; Baron S; Mampay M; Allen MC; Samuels M; Jones W; Cilibrasi C; Flaherty RL; Giamas G; Thaker PH; Flint MS
    Brain Behav Immun; 2023 May; 110():1-12. PubMed ID: 36796704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
    Ju X; Zhang H; Zhou Z; Chen M; Wang Q
    Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle.
    Krimmer DI; Loseli M; Hughes JM; Oliver BG; Moir LM; Hunt NH; Black JL; Burgess JK
    Allergy; 2009 Jul; 64(7):1074-82. PubMed ID: 19220210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer.
    Imai D; Yoshizumi T; Okano S; Itoh S; Ikegami T; Harada N; Aishima S; Oda Y; Maehara Y
    J Surg Res; 2019 Aug; 240():115-123. PubMed ID: 30927618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
    Tanaka F; Kawakami A; Tamai M; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Huang M; Kamachi M; Ida H; Origuchi T; Eguchi K
    Int J Mol Med; 2005 May; 15(5):833-9. PubMed ID: 15806306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes.
    Kondo A; Yamashita T; Tamura H; Zhao W; Tsuji T; Shimizu M; Shinya E; Takahashi H; Tamada K; Chen L; Dan K; Ogata K
    Blood; 2010 Aug; 116(7):1124-31. PubMed ID: 20472834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rhamnazin Enhanced Anti-Tumor Efficacy of Anti-PD-1 Therapy for Lung Cancer in Mice through Inhibition of PD-L1 Expression.
    Wang SS; Liu Y; Zhang XT; Yu DQ
    Tohoku J Exp Med; 2023 May; 260(1):63-73. PubMed ID: 36823182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of CYLD promotes IFN-γ mediated PD-L1 expression in thymic epithelial tumors.
    Umemura S; Zhu J; Chahine JJ; Kallakury B; Chen V; Kim IK; Zhang YW; Goto K; He Y; Giaccone G
    Lung Cancer; 2020 Sep; 147():221-228. PubMed ID: 32738418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.